(EMAILWIRE.COM, January 16, 2019 ) The overall diagnostic catheters market is projected to reach USD 4,302.3 million by 2021 from USD 3,025.8 million in 2016, at a CAGR of 7.3% from 2016 to 2021. Advancements in medical imaging technologies, increasing number of minimally invasive procedures, launch of new technologies in terms of catheter design, and rising geriatric population (resulting in a subsequent growth in the prevalence of chronic disorders) are primarily expected to drive growth in the global market. However, factors such as dearth of skilled professionals, high cost of technologically advanced catheters, and the trend of reusing single-use diagnostic catheters are expected to restrain market growth to a certain extent.

Growing preference of OCT imaging catheters in intravascular diagnostics and imaging:

OCT has revolutionized the medical imaging industry and has extended its applications in disease diagnosis and imaging of various cellular and molecular processes in vivo. The successful application of OCT imaging in various diagnostic areas such as cardiology has resulted in greater adoption of OCT imaging catheters by doctors for various diagnostic indications. The resolution limits of coronary angiography, along with the need for greater precision during percutaneous interventions have resulted in increased demand for high-resolution intracoronary imaging techniques such as OCT. These varied advantages of OCT imaging have drawn a number of market players to launch new OCT imaging systems and catheters for diagnostic applications. In October 2013, St. Jude Medical launched an OCT-assisted system for coronary imaging in the US.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=114053400

Major Market Developments:

In October 2015, Cardinal Health, Inc. acquired Johnson & Johnson's (U.S.) Cordis business, a global player in the cardiovascular and endovascular devices market. The acquisition enhanced Cardinal Health's portfolio of diagnostic catheters used in cardiology and endovascular applications, helping Cardinal Health to strengthen its position in the global market, specifically in the cardiovascular area.

In February 2015, Royal Philips (U.S.), a part of Koninklijke Philips N.V., acquired Volcano Corporation (U.S.), a global leader in intravascular imaging for coronary and peripheral therapeutic devices. This acquisition has helped the company to become a leading systems integrator in the fast-growing image-guided MIS market.

In October 2013, St. Jude Medical launched OCT-assisted system for coronary imaging in the U.S. This system uses St. Jude’s Dragonfly Duo Imaging catheter to capture near-infrared light. This launch has enhanced the company’s portfolio for advanced diagnostic catheters in the US market.

Know more in detail analysis of global Diagnostic Catheter Market :
https://www.marketsandmarkets.com/Market-Reports/diagnostic-catheter-market-114053400.html